ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 199.6 | 166.8 | 166.7 |
| Other income | 4.2 | 2.5 | 5.7 |
| Total income | 203.8 | 169.3 | 172.4 |
| Profit before exceptional items & tax | 0.8 | -4.0 | -4.8 |
| Exceptional items | 2.7 | 2.7 | 11.3 |
| Profit before tax | 3.6 | -1.2 | 6.6 |
| Net profit | 2.2 | -1.0 | 4.0 |
| Operating margin | 1.8% | -0.7% | 3.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -45.00% |
|---|---|
| Revenue, year on year | +19.70% |
| Operating profit, year on year | +67.60% |
| Operating profit, quarter on quarter | +47.70% |
NSE results filing, NSE: PANACEABIO. Figures extracted from the filing.
Panacea Biotec Ltd: key numbers
- Share price
- ₹353.70
- Market cap
- ₹2,166 Cr
- Revenue (annual)
- ₹639.8 Cr
- Net profit (annual)
- ₹-5.38 Cr
- P/E (TTM)
- -304.3×Sector 43.8×
- Promoter holding
- 72.48%+0.00% QoQ
- FII holding
- 2.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Panacea Biotec Ltd
All →Panacea Biotec Board Meeting Date
Panacea Biotec notified BSE and NSE of a board meeting on 14 November 2026 to approve provisional unaudited quarterly and half-year results. The trading window stays closed till 16 November 2026.
Panacea Biotec Annual General Meeting
Panacea Biotec held its 42nd Annual General Meeting on September 29, 2026, where members considered and adopted various financial and operational business items.
Panacea Biotec Legal & Regulatory
Panacea Biotec received two Income Tax demand orders totaling ₹4.32 Crore for alleged income misreporting. The company disputes the demand and plans to file an appeal.
- Value
- ₹4.32 Cr
Panacea Biotec Legal & Regulatory
Panacea Biotec received four income tax demand orders totaling ₹9.82 Crore for alleged misreporting. The company contests this as non-maintainable and plans to appeal.
- Value
- ₹9.82 Cr
Panacea Biotec Other Announcement
Panacea Biotec sent reminder letters to physical shareholders requesting PAN and KYC updates per SEBI circulars. No transaction or business event is involved.
Panacea Biotec Annual General Meeting
Panacea Biotec Limited issued the notice for its 42nd Annual General Meeting scheduled for September 29, 2026, via video conferencing. Shareholders can participate through remote e-voting.